Literature DB >> 9759920

Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6.

R Mössner1, A Heils, G Stöber, O Okladnova, S Daniel, K P Lesch.   

Abstract

Serotonin (5-HT) is a prime candidate for studies of the interaction between the nervous and immune systems, since it is both an important neurotransmitter and released at high concentrations at sites of inflammation. Serotonergic neurotransmission is regulated by the 5-HT transporter (5-HTT), which determines the magnitude and duration of serotonergic responses. Since tumor necrosis factor alpha (TNF-alpha) and interleukin-6 are two inflammatory mediators that are central to the initiation of inflammation, we studied the impact of these cytokines on the 5-HTT. As model system we used a cell line which constitutively expresses the 5-HTT, namely the choriocarcinoma cell line JAR. We found that TNF-alpha enhances 5-HT uptake, with a doubling of the maximal velocity of uptake. Interleukin-6, on the other hand, had no effect. We thus show for the first time that the cytokine TNF-alpha modulates 5-HTT function. Furthermore, we propose a molecular mechanism for this effect. Since both 5-HT and TNF-alpha are elevated at sites of inflammation, TNF-alpha may act to renormalize 5-HT levels by way of its effect on the 5-HTT. This is especially important for the central nervous system, where the TNF-alpha effect shown here can aid in preventing disturbances of serotonergic neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9759920     DOI: 10.1016/s0197-0186(98)00026-6

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  29 in total

1.  A cytokine study in children and adolescents with Tourette's disorder.

Authors:  Vilma Gabbay; Barbara J Coffey; Leah E Guttman; Lev Gottlieb; Yisrael Katz; James S Babb; Mia M Hamamoto; Charles J Gonzalez
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-05-07       Impact factor: 5.067

Review 2.  Toward a biosignature for suicide.

Authors:  Maria A Oquendo; Gregory M Sullivan; Katherin Sudol; Enrique Baca-Garcia; Barbara H Stanley; M Elizabeth Sublette; J John Mann
Journal:  Am J Psychiatry       Date:  2014-10-31       Impact factor: 18.112

Review 3.  Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

Authors:  J C Felger; F E Lotrich
Journal:  Neuroscience       Date:  2013-05-03       Impact factor: 3.590

Review 4.  Inflammatory cytokine-associated depression.

Authors:  Francis E Lotrich
Journal:  Brain Res       Date:  2014-07-05       Impact factor: 3.252

5.  Interaction analysis between 5-HTTLPR and TNFA -238/-308 polymorphisms in schizophrenia.

Authors:  C-U Pae; A Serretti; P Artioli; T-S Kim; J-J Kim; C-U Lee; S-J Lee; I-H Paik; C Lee
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 6.  Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.

Authors:  Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Ther       Date:  2011-04-05       Impact factor: 12.310

7.  Serotonin 5-HT(2A) Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases.

Authors:  Charles D Nichols
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-10-13

Review 8.  A dialogue between the immune system and brain, spoken in the language of serotonin.

Authors:  Nicole L Baganz; Randy D Blakely
Journal:  ACS Chem Neurosci       Date:  2012-12-07       Impact factor: 4.418

9.  The pro-inflammatory cytokine TNF-α regulates the activity and expression of the serotonin transporter (SERT) in astrocytes.

Authors:  Sandra Malynn; Antonio Campos-Torres; Paul Moynagh; Jana Haase
Journal:  Neurochem Res       Date:  2013-01-22       Impact factor: 3.996

Review 10.  Brain interleukin-15 in neuroinflammation and behavior.

Authors:  Weihong Pan; Xiaojun Wu; Yi He; Hung Hsuchou; Eagle Yi-Kung Huang; Pramod K Mishra; Abba J Kastin
Journal:  Neurosci Biobehav Rev       Date:  2012-11-29       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.